Brussels, 24 August 2013 - Three hospitals in Syria's Damascus governorate that are supported by the international medical humanitarian organisation Médecins Sans Frontières (MSF) have reported to MSF that they received approximately 3,600 patients displaying neurotoxic symptoms in less than three hours on the morning of Wednesday, August 21, 2013. Of those patients, 355 reportedly died.
Since 2012, MSF has built a strong and reliable collaboration with medical networks, hospitals and medical points in the Damascus governorate, and has been providing them with drugs, medical equipment and technical support. Due to significant security risks, MSF staff members have not been able to access the facilities.
“Medical staff working in these facilities provided detailed information to MSF doctors regarding large numbers of patients arriving with symptoms including convulsions, excess saliva, pinpoint pupils, blurred vision and respiratory distress,” said Dr Bart Janssens, MSF director of operations.
Patients were treated using MSF-supplied atropine, a drug used to treat neurotoxic symptoms. MSF is now trying to replenish the facilities’ empty stocks and provide additional medical supplies and guidance.
“MSF can neither scientifically confirm the cause of these symptoms nor establish who is responsible for the attack,” said Dr Janssens. “However, the reported symptoms of the patients, in addition to the epidemiological pattern of the events—characterised by the massive influx of patients in a short period of time, the origin of the patients, and the contamination of medical and first aid workers—strongly indicate mass exposure to a neurotoxic agent. This would constitute a violation of international humanitarian law, which absolutely prohibits the use of chemical and biological weapons.”
Saturday, August 24, 2013
Additional proof of nerve gas attack in Syria from Doctors Without Borders
Doctors Without Borders, which both has medical personnel in Syria and gives support to medical facilities in the Damascus area, reports that thousands suffering neurotoxic symptoms treated in hospitals supported by MSF.